Confluence Investment Management Llc decreased its stake in Glaxosmithkline Plc (Adr 1:2) (GSK) by 63.85% based on its latest 2019Q2 regulatory filing with the SEC. Confluence Investment Management Llc sold 313,692 shares as the company’s stock rose 2.15% . The institutional investor held 177,603 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $7.11 million, down from 491,295 at the end of the previous reported quarter. Confluence Investment Management Llc who had been investing in Glaxosmithkline Plc (Adr 1:2) for a number of months, seems to be less bullish one the $111.85B market cap company. The stock increased 0.94% or $0.42 during the last trading session, reaching $45.07. About 2.98 million shares traded or 15.88% up from the average. GlaxoSmithKline plc (NYSE:GSK) has risen 0.49% since December 4, 2018 and is uptrending. It has outperformed by 0.49% the S&P500.
Confluence Investment Management Llc, which manages about $2.30B and $6.25B US Long portfolio, upped its stake in Cannae Holdings Inc by 308,840 shares to 616,167 shares, valued at $17.86M in 2019Q2, according to the filing.
Analysts await GlaxoSmithKline plc (NYSE:GSK) to report earnings on February, 5. They expect $0.68 earnings per share, down 13.92 % or $0.11 from last year’s $0.79 per share. GSK’s profit will be $1.69B for 16.57 P/E if the $0.68 EPS becomes a reality. After $0.95 actual earnings per share reported by GlaxoSmithKline plc for the previous quarter, Wall Street now forecasts -28.42 % negative EPS growth.
More notable recent GlaxoSmithKline plc (NYSE:GSK) news were published by: Fool.com which released: “Better Buy: AbbVie vs. GlaxoSmithKline – The Motley Fool” on November 24, 2019, also Fool.com with their article: “1 Attractive Pharma Stock You Probably Haven’t Heard Of – Motley Fool” published on November 21, 2019, Seekingalpha.com published: “Glaxo’s Nucala successful in pivotal HES study – Seeking Alpha” on November 13, 2019. More interesting news about GlaxoSmithKline plc (NYSE:GSK) were released by: Seekingalpha.com and their article: “Pfizer: Grab The Popcorn, Wait And See – Seeking Alpha” published on November 26, 2019 as well as Finance.Yahoo.com‘s news article titled: “Bayer and Teva Double Down on Worst M&A Deals of Decade – Yahoo Finance” with publication date: December 04, 2019.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.